Church & Dwight Co., Inc. (NYSE:CHD) Shares Sold by Oppenheimer Asset Management Inc.

Oppenheimer Asset Management Inc. reduced its stake in shares of Church & Dwight Co., Inc. (NYSE:CHD) by 23.0% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 15,385 shares of the company’s stock after selling 4,585 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Church & Dwight were worth $1,611,000 at the end of the most recent quarter.

Other large investors have also recently added to or reduced their stakes in the company. Holocene Advisors LP acquired a new stake in shares of Church & Dwight in the 3rd quarter worth approximately $104,795,000. State Street Corp raised its holdings in Church & Dwight by 8.0% during the third quarter. State Street Corp now owns 13,116,334 shares of the company’s stock worth $1,373,542,000 after purchasing an additional 969,006 shares in the last quarter. World Investment Advisors LLC acquired a new stake in Church & Dwight in the third quarter worth approximately $58,338,000. Barclays PLC boosted its stake in Church & Dwight by 63.9% during the 3rd quarter. Barclays PLC now owns 1,106,131 shares of the company’s stock valued at $115,832,000 after purchasing an additional 431,257 shares in the last quarter. Finally, Massachusetts Financial Services Co. MA increased its position in shares of Church & Dwight by 5.7% during the 3rd quarter. Massachusetts Financial Services Co. MA now owns 8,016,345 shares of the company’s stock valued at $839,472,000 after purchasing an additional 429,863 shares during the period. 86.60% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of research firms recently issued reports on CHD. Piper Sandler lowered their target price on Church & Dwight from $128.00 to $126.00 and set an “overweight” rating on the stock in a report on Monday, February 3rd. Truist Financial boosted their target price on shares of Church & Dwight from $110.00 to $115.00 and gave the stock a “buy” rating in a report on Monday, February 3rd. Deutsche Bank Aktiengesellschaft increased their target price on shares of Church & Dwight from $114.00 to $115.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Wells Fargo & Company upped their price target on Church & Dwight from $113.00 to $115.00 and gave the company an “overweight” rating in a report on Monday, November 4th. Finally, Stifel Nicolaus increased their price objective on Church & Dwight from $103.00 to $105.00 and gave the company a “hold” rating in a research report on Monday, February 3rd. Two investment analysts have rated the stock with a sell rating, seven have issued a hold rating and seven have issued a buy rating to the company. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $111.56.

Church & Dwight Stock Performance

CHD stock opened at $112.00 on Tuesday. The stock has a market cap of $27.55 billion, a P/E ratio of 47.26, a P/E/G ratio of 3.32 and a beta of 0.59. The company has a debt-to-equity ratio of 0.51, a quick ratio of 1.24 and a current ratio of 1.70. The firm has a 50 day simple moving average of $105.84 and a 200 day simple moving average of $105.12. Church & Dwight Co., Inc. has a 52 week low of $96.35 and a 52 week high of $113.50.

Church & Dwight (NYSE:CHD) last posted its quarterly earnings results on Friday, January 31st. The company reported $0.77 EPS for the quarter, meeting the consensus estimate of $0.77. Church & Dwight had a net margin of 9.58% and a return on equity of 20.03%. During the same quarter in the previous year, the company posted $0.65 EPS. Research analysts anticipate that Church & Dwight Co., Inc. will post 3.7 earnings per share for the current fiscal year.

Church & Dwight Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, March 3rd. Stockholders of record on Friday, February 14th were paid a dividend of $0.295 per share. The ex-dividend date of this dividend was Friday, February 14th. This is an increase from Church & Dwight’s previous quarterly dividend of $0.28. This represents a $1.18 dividend on an annualized basis and a dividend yield of 1.05%. Church & Dwight’s dividend payout ratio (DPR) is 49.79%.

Insider Activity

In related news, EVP Michael Read purchased 1,100 shares of Church & Dwight stock in a transaction on Monday, December 16th. The stock was bought at an average price of $106.82 per share, with a total value of $117,502.00. Following the completion of the transaction, the executive vice president now directly owns 2,505 shares of the company’s stock, valued at approximately $267,584.10. This represents a 78.29 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Ravichandra Krishnamu Saligram sold 10,000 shares of the firm’s stock in a transaction that occurred on Monday, December 16th. The shares were sold at an average price of $106.11, for a total value of $1,061,100.00. Following the completion of the transaction, the director now directly owns 32,500 shares in the company, valued at $3,448,575. The trade was a 23.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 2.00% of the stock is owned by corporate insiders.

Church & Dwight Profile

Church & Dwight Co, Inc engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements.